HEPION PHARMACEUTICALS, INC. Shareholders' Equity
HEPION PHARMACEUTICALS, INC. (HEPA) had Shareholders' Equity of $1.28 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $1.28M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $1.86M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $2.67M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $3.32M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $1.28M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $1.86M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $2.67M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $3.32M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $3.80M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $3.90M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | -$1.86M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $406.69K 10-Q · filed 2025-11-12 | -$406.69K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $3.56M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $7.52M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $7.28M 10-K · filed 2026-03-12 | |
| 2023-09-30 | $16.16M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $26.37M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $37.15M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $49.86M 10-K · filed 2025-04-08 | |
| 2022-09-30 | $59.26M 10-Q · filed 2023-11-20 | |
| 2022-06-30 | $67.32M 10-Q · filed 2023-11-20 | |
| 2022-03-31 | $86.64M 10-Q · filed 2023-11-20 | |
| 2021-12-31 | $93.00M 10-K · filed 2024-04-16 | |
| 2021-09-30 | $102.64M 10-Q · filed 2022-11-14 | $102.64M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $110.72M 10-Q · filed 2022-11-14 | $110.72M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $117.58M 10-Q · filed 2022-11-14 | $117.57M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $40.52M 10-K · filed 2023-04-10 | |
| 2020-09-30 | $12.87M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $17.72M 10-Q · filed 2021-11-15 | $18.29M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $18.20M 10-Q · filed 2021-11-15 | $18.77M 10-Q · filed 2020-06-29 |
| 2019-12-31 | $15.62M 10-K · filed 2022-04-08 | $16.19M 10-K · filed 2020-05-14 |
| 2019-09-30 | $15.98M 10-Q · filed 2020-11-16 | $16.23M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $17.78M 10-Q · filed 2020-11-16 | $18.03M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $394.79K 10-Q · filed 2020-11-16 | $645.46K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $1.72M 10-K · filed 2021-03-31 | $1.98M 10-K · filed 2019-03-14 |
| 2018-09-30 | $4.65M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | -$752.57K 10-Q · filed 2019-08-14 | -$751.52K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $3.05M 10-Q · filed 2019-11-14 | $3.05M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $3.70M 10-K · filed 2020-05-14 | |
| 2017-09-30 | $4.99M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $9.06M 10-K · filed 2019-03-14 | |
| 2017-03-31 | -$385.42K 10-Q · filed 2017-04-12 | |
| 2016-12-31 | $5.88M 10-Q · filed 2017-02-14 | |
| 2016-09-30 | -$3.00M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $1.32M 10-K · filed 2019-03-14 | |
| 2016-03-31 | $1.30M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $4.98M 10-Q · filed 2016-02-12 | |
| 2015-09-30 | -$1.36M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $3.44M 10-KT · filed 2018-03-26 | |
| 2015-03-31 | $7.88M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $8.60M 10-Q · filed 2015-02-12 | |
| 2014-09-30 | $539.87K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | -$2.93M 10-K · filed 2016-09-28 | |
| 2014-03-31 | -$7.34M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | -$489.86K 10-Q · filed 2014-02-05 | |
| 2013-09-30 | -$322.56K 10-Q · filed 2013-11-19 | |
| 2013-06-30 | -$140.50K 10-K · filed 2015-09-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |